AAAAAA
Results:
1-7
|
Results: 7
Authors:
Miyake, Y
Yokota, K
Fujishima, Y
Sukamoto, T
Citation: Y. Miyake et al., The effects of danaparoid, dalteparin and heparin on tissue factor-inducedexperimental disseminated intravascular coagulation and bleeding time in the rat, BL COAG FIB, 12(5), 2001, pp. 349-357
Authors:
Yoshitake, K
Yokota, K
Kasugai, Y
Kagawa, M
Sukamoto, T
Nakamura, T
Citation: K. Yoshitake et al., Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet, BONE, 25(3), 1999, pp. 311-319
Authors:
Ozaki, A
Sukamoto, T
Citation: A. Ozaki et T. Sukamoto, Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist, GEN PHARM, 33(3), 1999, pp. 283-288
Authors:
Hara, H
Shimazawa, M
Sasaoka, M
Yamada, C
Iwakura, Y
Sakai, T
Maeda, Y
Yamaguchi, T
Sukamoto, T
Hashimoto, M
Citation: H. Hara et al., Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs, CLIN EXP PH, 26(11), 1999, pp. 870-876
Authors:
Ozaki, A
Fujishima, Y
Sukamoto, T
Citation: A. Ozaki et al., Selective 5-hydroxytryptamine(3) (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative, JPN J PHARM, 80(1), 1999, pp. 25-32
Authors:
Ozaki, A
Yoshidomi, M
Sukamoto, T
Citation: A. Ozaki et al., Effect of the 5-hydroxytryptamine(3) (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models, JPN J PHARM, 80(1), 1999, pp. 93-96
Authors:
Yoshizumi, K
Ikeda, S
Goto, K
Morita, T
Nishimura, N
Sukamoto, T
Yoshino, K
Citation: K. Yoshizumi et al., Synthesis and structure-activity relationships of novel phenylcyanoguanidine derivatives as potassium channel operators (vol 44, pg 2042, 1996), CHEM PHARM, 46(12), 1998, pp. 1952-1952
Risultati:
1-7
|